Dermatology 2007-01-01

Steroid-sparing effect of pimecrolimus cream 1% in children with severe atopic dermatitis.

Torsten Zuberbier, Lucie Heinzerling, Thomas Bieber, Uwe Schauer, Sven Klebs, Matthias Bräutigam

Index: Dermatology 215(4) , 325-30, (2007)

Full Text: HTML

Abstract

To investigate if pimecrolimus cream 1% reduces the need for steroids in the long-term management of severe pediatric atopic dermatitis (AD).A total of 184 pediatric patients (aged 2-17 years) with a history of severe AD according to Rajka and Langeland were enrolled. Patients were randomized to treatment with pimecrolimus cream or vehicle cream for a 24-week period. Prednicarbate 0.25% was applied as rescue medication.Patients on pimecrolimus required steroids on a mean of 29% of study days, compared with 35% of patients on vehicle (p = 0.1841). On the head and neck only, the respective figures were 10 versus 19% (p = 0.0009). In patients enrolled with acute severe disease (Investigator's Global Assessment > or = 4), steroids were used on 28% of the days in the pimecrolimus group compared to 45% in the control group (p = 0.0024). On the head and neck, steroids were used on 10% of study days with pimecrolimus versus 30% with vehicle (p < 0.0001).The results indicate that the need for topical steroids on the head and neck is reduced with pimecrolimus cream 1% in the management of severe pediatric AD according to the definition of Rajka and Langeland.2007 S. Karger AG, Basel

Related Compounds

  • Prednicarbate

Related Articles:

Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective.

2013-10-01

[J. Cancer Res. Clin. Oncol. 139(10) , 1667-72, (2013)]

Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids.

2011-01-01

[Skin Pharmacol. Physiol. 24(4) , 199-209, (2011)]

Efficacy of crisis intervention treatment with topical corticosteroid prednicarbat with and without partial wet-wrap dressing in atopic dermatitis.

2006-01-01

[Dermatology 212(1) , 66-9, (2006)]

Transcriptional activity of potent glucocorticoids: relevance of glucocorticoid receptor isoforms and drug metabolites.

2003-01-01

[Skin Pharmacol. Appl. Skin Physiol. 16(3) , 143-50, (2003)]

Modern topical glucocorticoids and anti-infectives for superinfected atopic eczema: do prednicarbate and didecyldimethylammoniumchloride form a rational combination?

1994-01-01

[Infection 22(6) , 390-4, (1994)]

More Articles...